HiFiBiO Release: SAS Announces Participation In Next Generation Antibody Therapeutics Session Along With Adimab, F-Star And Innovative Targeting Solutions At Biointernational 2016 In San Francisco, USA

PARIS, France--(BUSINESS WIRE)--In an interactive session at BioInternational 2016, HiFiBiO, Adimab, F-Star and Innovative Targeting Solutions join together to present next-generation therapeutic antibody technologies designed to help deliver the next wave of antibody therapeutics to the pipeline.

Session title: Tackling Tough Targets with a New Wave of Antibody Technologies

Moderator: Paul Kang- (Innovative Targeting Solutions Inc., Canada)

Speakers: Colin Brenan (HiFiBiO, France), John Haurum (F-star, UK), Eric Krauland, (Adimab, USA)